What are the recommended eye drops for managing pterygium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Eye Drops for Managing Pterygium

Preservative-free hyaluronate eye drops are the first-line treatment for managing pterygium, providing essential lubrication to reduce irritation and protect the ocular surface. 1, 2

First-Line Treatment Options

  • Preservative-free hyaluronate drops are recommended as the primary treatment for pterygium, typically applied 2-4 times daily to maintain adequate lubrication of the ocular surface 1
  • Carboxymethylcellulose 0.5-1% or carmellose sodium can be used as alternative lubricants when hyaluronate drops are not available 1
  • For nocturnal symptoms, petrolatum ointment can be applied at night to provide extended protection 1
  • Lipid-containing eye drops are particularly beneficial when there is concurrent meibomian gland dysfunction 1

Treatment Algorithm Based on Severity

Mild Pterygium

  • Begin with preservative-free hyaluronate drops 2-4 times daily 1
  • Frequency may need to be increased up to half-hourly in more symptomatic cases 1
  • Higher percentage hyaluronate formulations offer greater therapeutic efficacy and should be used in more severe disease 1

Moderate to Severe Pterygium

  • Continue preservative-free lubricants as baseline therapy 1
  • Add topical corticosteroid eye drops for short-term management of inflammation (maximum 8 weeks) 1
  • Loteprednol etabonate ophthalmic suspension may be used, one drop four times daily 3
  • Monitor intraocular pressure if corticosteroid eye drops are used for more than 10 days 3

Special Considerations

  • Patients with ectropion should receive more frequent ocular lubricants as first-line treatment 1
  • Eyelid emollients and massage (vertical lid massage and stretching) can improve associated lagophthalmos and ectropion 1
  • For patients with significant inflammation, short-term topical corticosteroids may be beneficial, with a 74% response rate reported in ocular surface disorders 1

Surgical Management Considerations

  • When pterygium causes visual disturbance, astigmatism, or approaches the visual axis, surgical intervention should be considered 4, 5
  • Post-surgical management includes:
    • Topical steroids to reduce inflammation 6
    • Preservative-free lubricants to promote healing and comfort 6
    • Long-term UV protection to prevent recurrence 6

Important Precautions

  • Avoid preservative-containing eye drops for long-term use as they may cause irritation and allergic contact dermatitis 1
  • If using corticosteroid eye drops, limit duration to avoid complications such as increased intraocular pressure and potential fungal infections 3
  • Regular ophthalmological follow-up is essential to monitor disease progression and treatment response 1
  • If symptoms worsen despite treatment, prompt ophthalmological reassessment is necessary 3

Treatment Efficacy

  • Ocular lubricants have shown a 65% good or very good response rate in managing ocular surface disorders 1
  • Topical corticosteroids demonstrate a 74% response rate but should be used judiciously due to potential side effects 1
  • Antihistamine eye drops show limited efficacy (42% response rate) and should be considered only as adjunctive therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Sodium Hyaluronate in Ocular Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on overview of pterygium and its surgical management.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Research

[Pterygium: etiology, pathogenesis, treatment].

Vestnik oftalmologii, 2017

Research

[Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.